🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This trial is designed to assess the tolerability, safety, pharmacokinetic ...
Status
Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2025-05-20
Trial ID
NCT06938880
Treatments Being Tested
PART 1: 1. To explore the safety of ZG005 in combination with Gecacitinib ...
Status
Recruiting
Location
The First Affiliated Hospital, Zhejiang University School of Medicine
Start Date
2025-05-16
Trial ID
NCT06883526
Treatments Being Tested
This study is a randomized, open-label, positive-controlled, multicenter ph...
Status
Recruiting
Location
West China Hospital of Sichuan University
Start Date
2024-10-24
Trial ID
NCT06558227
Treatments Being Tested
This is a multicenter, open-label phase I/II study for the first-line treat...
Status
Unknown
Location
Zhejiang Cancer Hospital
Start Date
2024-03-27
Trial ID
NCT06241235
Treatments Being Tested
This is a Multi-center, Open-labe, Phase I/II Study to evaluate the safety ...
Status
Unknown
Location
The Second Affiliated Hospital of Army Medical University
Start Date
2024-05-10
Trial ID
NCT06239298
Treatments Being Tested
This is a randomized, open-label study to evaluate the safety and efficacy ...
Status
Unknown
Location
Changsha Taihe Hospital
Start Date
2024-01
Trial ID
NCT06233994
Treatments Being Tested
This is a multicenter Phase I/II study for patients with advanced non-small...
Status
Recruiting
Location
Shanghai Chest Hospital
Start Date
2025-05-23
Trial ID
NCT06903377
Treatments Being Tested
This is an open-label, multicenter, Phase II clinical trial, designed to ev...
Status
Active Not Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2025-06-13
Trial ID
NCT06927687
Treatments Being Tested
The trial is divided into two parts. PART 1 is a dose escalation study of t...
Status
Recruiting
Location
Chinese PLA General Hospital
Start Date
2024-05-30
Trial ID
NCT06372626
This is a multi-center, open-label, Phase 1/2 study of ZG005 for the treatm...
Status
Unknown
Location
Zhejiang Cancer Hospital
Start Date
2022-06-17
Trial ID
NCT06233292
Treatments Being Tested